Literature DB >> 12084329

Alpha-blockers: an effective treatment for prostatitis?

D Caropreso1, T D Moon.   

Abstract

Chronic prostatitis is a multifaceted problem affecting men that is both poorly understood and poorly treated. It is inevitable, therefore, that no single treatment will benefit all patients. However, data suggest that some patients' problems can be treated effectively with alpha-blockers. The prostate is rich in alpha-adrenergic receptors, and some urodynamic studies have shown a failure of the bladder neck to relax during voiding. Other studies have demonstrated turbulent flow in the prostate leading to prostatic duct reflux. Because urine is acidic, reflux into the prostatic ducts will cause inflammation and pain. Thus alpha-blockers are an effective treatment for men with prostatitis caused by dysfunctional voiding.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 12084329     DOI: 10.1007/s11934-000-0050-0

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  42 in total

Review 1.  Prostatitis, prostatosis, and prostatodynia.

Authors:  S M Orland; P M Hanno; A J Wein
Journal:  Urology       Date:  1985-05       Impact factor: 2.649

2.  KMD-3213, a uroselective and long-acting alpha(1a)-adrenoceptor antagonist, tested in a novel rat model.

Authors:  K Akiyama; M Hora; S Tatemichi; N Masuda; S Nakamura; R Yamagishi; M Kitazawa
Journal:  J Pharmacol Exp Ther       Date:  1999-10       Impact factor: 4.030

3.  Alfuzosin for treatment of benign prostatic hypertrophy. The BPH-ALF Group.

Authors:  A Jardin; H Bensadoun; M C Delauche-Cavallier; P Attali
Journal:  Lancet       Date:  1991-06-15       Impact factor: 79.321

4.  Urodynamic evidence of vesical neck obstruction in men with misdiagnosed chronic nonbacterial prostatitis and the therapeutic role of endoscopic incision of the bladder neck.

Authors:  S A Kaplan; A E Te; B Z Jacobs
Journal:  J Urol       Date:  1994-12       Impact factor: 7.450

5.  Tamsulosin, a selective alpha 1c-adrenoceptor antagonist: a randomized, controlled trial in patients with benign prostatic 'obstruction' (symptomatic BPH). The European Tamsulosin Study Group.

Authors:  P Abrams; C C Schulman; S Vaage
Journal:  Br J Urol       Date:  1995-09

6.  [Symptomatic treatment of benign hypertrophy of the prostate. Comparative study of prazosin and serenoa repens].

Authors:  M Adriazola Semino; J L Lozano Ortega; E García Cobo; E Tejeda Báñez; F Romero Rodríguez
Journal:  Arch Esp Urol       Date:  1992-04       Impact factor: 0.436

7.  A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia.

Authors:  H Lepor; S Auerbach; A Puras-Baez; P Narayan; M Soloway; F Lowe; T Moon; G Leifer; P Madsen
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

8.  The evaluation of bladder neck dysfunction.

Authors:  G D Webster; J L Lockhart; R A Older
Journal:  J Urol       Date:  1980-02       Impact factor: 7.450

9.  Coagulase-negative staphylococcus in chronic prostatitis.

Authors:  J C Nickel; J W Costerton
Journal:  J Urol       Date:  1992-02       Impact factor: 7.450

10.  Research in 'prostatitis syndromes': the use of alfuzosin (a new alpha 1-receptor-blocking agent) in patients mainly presenting with micturition complaints of an irritative nature and confirmed urodynamic abnormalities.

Authors:  J J de la Rosette; H F Karthaus; P E van Kerrebroeck; T de Boo; F M Debruyne
Journal:  Eur Urol       Date:  1992       Impact factor: 20.096

View more
  1 in total

Review 1.  [Chronic pain syndrome in uorology].

Authors:  S Krege; M Ludwig; M Kloke; H Rübben
Journal:  Urologe A       Date:  2003-04-11       Impact factor: 0.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.